Rajkamal Synthetics appoints Mumal Kanwar as CFO and KMP
- Mumal Kanwar appointed as CFO and KMP effective September 26, 2026
- Board approved the appointment on September 28, 2026
- Kanwar is Associate Member of ICSI with experience in corporate compliance
- Disclosed as sister-in-law of MD & CEO Ankur Ajmera

*this image is generated using AI for illustrative purposes only.
Rajkamal Synthetics Limited has appointed Mumal Kanwar as its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) with immediate effect. The appointment was approved by the Board of Directors on September 28, 2026, with an effective date of September 26, 2026.
Appointment details and profile
Kanwar brings experience in corporate laws, regulatory matters, and secretarial compliances to the role. She is an Associate Member of the Institute of Company Secretaries of India (ICSI) and holds a Post-Graduate degree from the University of Rajasthan. Her tenure with the company includes handling corporate and operational affairs.
The disclosure highlights a related-party connection: Kanwar is the sister-in-law of Ankur Ajmera, the Managing Director and CEO of the company. The terms of her appointment are as approved by the Board.
Regulatory compliance and disclosures
The intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III. The company confirmed that Kanwar is not debarred from holding the office of CFO or KMP by any SEBI order or other authority.
| Detail | Information |
|---|---|
| Appointee | Mumal Kanwar |
| Role | Chief Financial Officer and Key Managerial Personnel |
| Effective Date | September 26, 2026 |
| Board Approval Date | September 28, 2026 |
| Qualification | Associate Member, ICSI; PG Degree, University of Rajasthan |
| Relationship | Sister-in-law of MD & CEO Ankur Ajmera |
Governance implications
The appointment underscores the continuity of family involvement in senior management roles at Rajkamal Synthetics. By designating a relative of the MD as a Key Managerial Personnel, the company aligns with common governance structures in promoter-led firms, provided all regulatory disclosures regarding related-party relationships are strictly maintained. The filing explicitly addresses the relationship requirement under SEBI guidelines, ensuring transparency for shareholders regarding the familial link between the new CFO and the CEO.
Historical Stock Returns for Rajkamal Synthetics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.13% | -1.57% | -5.19% | -45.42% | -53.15% | 0.0% |
How might the familial relationship between the new CFO and MD influence independent audit processes and internal control assessments for Rajkamal Synthetics?
What specific regulatory scrutiny or enhanced disclosure requirements are likely to emerge from SEBI regarding this related-party appointment?
Will the appointment of a secretarial compliance expert as CFO signal a strategic shift towards prioritizing regulatory risk management over traditional financial reporting?































